MedPath

Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System

Completed
Conditions
Diabetes Mellitus
Interventions
Device: FreeStyle Navigator Continuous Glucose Monitoring System
Registration Number
NCT00920881
Lead Sponsor
Abbott Diabetes Care
Brief Summary

To evaluate the clinical accuracy of the FreeStyle Navigator Continuous Glucose Monitoring System with respect to a reference standard.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • History consistent with type 1 diabetes
  • At least 18 years of age
  • Available and capable of following the protocol instructions provided by the healthcare professional
  • Signed and dated informed consent form
Exclusion Criteria
  • Pregnancy
  • Type 2, gestational, or secondary diabetes
  • Known allergy to medical grade adhesives
  • Skin abnormalities at the insertion sites that would confound the assessment of the effect of the device on the skin
  • Seizure disorder
  • Myocardial ischemia
  • History of stroke
  • Severe hypoglycemia unawareness
  • Other concomitant medical conditions that in the opinion of the investigator, would affect the evaluation of device performance and/or safety

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
DiabetesFreeStyle Navigator Continuous Glucose Monitoring System-
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Diablo Clinical Research

🇺🇸

Walnut Creek, California, United States

Ranier Clinical Research

🇺🇸

Renton, Washington, United States

Diabetes & Glandular Disease Clinic

🇺🇸

San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath